Table 1 Clinico-pathological characteristics and epidemiologic data of the series of MPM patients

From: Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

 

Exploration series (n = 63)

Validation series (n = 110)

Gender (n [%])

 Male

47 [75]

85 [77]

 Female

16 [25]

25 [23]

Age (years)

 Median ± SD

64 ± 10

71 ± 11

 Range

39–90

20–89

Histology (n [%])

 Epithelioid

49 [78]

81 [76]

 Biphasic

7 [11]

15 [8]

 Sarcomatoid

5 [8]

8 [7]

 Desmoplastic

1 [2]

2 [2]

Lymphohistiocytoid

1 [2]

0 [0]

Asbestos exposure (n [%])

 Exposed

47 [78]

75 [74]

 Non-exposed

13 [22]

26 [26]

Stage IMIG (n [%])

 I

2 [4]

3 [6]

 II

7 [14]

8 [16]

 III

25 [49]

23 [45]

 IV

17 [33]

17 [33]

Survival (months)

 Median

16.9

19.7

 Range

0.1–165.7

0.4–108.5

  1. MPM malignant pleural mesothelioma